Premium
The first clinical implementation of electromagnetic transponder‐guided MLC tracking
Author(s) -
Keall Paul J.,
Colvill Emma,
O’Brien Ricky,
Ng Jin Aun,
Poulsen Per Rugaard,
Eade Thomas,
Kneebone Andrew,
Booth Jeremy T.
Publication year - 2014
Publication title -
medical physics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 180
eISSN - 2473-4209
pISSN - 0094-2405
DOI - 10.1118/1.4862509
Subject(s) - transponder (aeronautics) , quality assurance , tracking (education) , nuclear medicine , medicine , dosimetry , computer science , medical physics , physics , psychology , pedagogy , external quality assessment , pathology , meteorology
Purpose: We report on the clinical process, quality assurance, and geometric and dosimetric results of the first clinical implementation of electromagnetic transponder‐guided MLC tracking which occurred on 28 November 2013 at the Northern Sydney Cancer Centre.Methods: An electromagnetic transponder‐based positioning system (Calypso) was modified to send the target position output to in‐house‐developed MLC tracking code, which adjusts the leaf positions to optimally align the treatment beam with the real‐time target position. Clinical process and quality assurance procedures were developed and performed. The first clinical implementation of electromagnetic transponder‐guided MLC tracking was for a prostate cancer patient being treated with dual‐arc VMAT (RapidArc). For the first fraction of the first patient treatment of electromagnetic transponder‐guided MLC tracking we recorded the in‐room time and transponder positions, and performed dose reconstruction to estimate the delivered dose and also the dose received had MLC tracking not been used.Results: The total in‐room time was 21 min with 2 min of beam delivery. No additional time was needed for MLC tracking and there were no beam holds. The average prostate position from the initial setup was 1.2 mm, mostly an anterior shift. Dose reconstruction analysis of the delivered dose with MLC tracking showed similar isodose and target dose volume histograms to the planned treatment and a 4.6% increase in the fractional rectal V 60 . Dose reconstruction without motion compensation showed a 30% increase in the fractional rectal V 60 from that planned, even for the small motion.Conclusions: The real‐time beam‐target correction method, electromagnetic transponder‐guided MLC tracking, has been translated to the clinic. This achievement represents a milestone in improving geometric and dosimetric accuracy, and by inference treatment outcomes, in cancer radiotherapy.